Bio Impact Capital LLC Black Diamond Therapeutics, Inc. Transaction History

Bio Impact Capital LLC

  • $641 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$1.27 - $2.51 $120,650 - $238,449
-95,000 Reduced 39.6%
144,888 $260,000
Q4 2021

Feb 11, 2022
SELL
$5.18 - $8.48 $44,641 - $73,080
-8,618 Reduced 3.47%
239,888 $1.28 Million
Q3 2021

Nov 15, 2021
BUY
$8.46 - $12.42 $1.73 Million - $2.54 Million
204,891 Added 469.77%
248,506 $2.1 Million
Q4 2020

Feb 16, 2021
BUY
$29.47 - $35.0 $1.29 Million - $1.53 Million
43,615 New
43,615 $1.4 Million

Others Institutions Holding BDTX

# of Institutions
121
Shares Held
48.8M
Call Options Held
1.84M
Put Options Held
1.93M
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $80.3M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email